BSD Medical Corp. develops, manufacturers, markets, and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy.
One of the company’s premier line of products is the MicroThermX Microwave Ablation System. It is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patent-use disposable antennas and a thermistor-based temperature monitoring system.
The company, on June 16th, reported positive results from the efforts of its sales and distribution network for the MicroThermX Microwave Ablation line of products. At the hospital level, more MicroThermX trained sales representatives are representing the advantages of the MicroThermX to those physicians interested in using a microwave technology platform for tumor ablations.
This increased sales activity has resulted in a full schedule of clinical evaluations in the coming weeks. These evaluations represent an important milestone in the MicroThermX sales cycle, with hospital capital budgeting, committee review and other approvals required to complete the sales cycle.
The company is excited by the initial sales from the rollout of its sales and marketing strategy. It also points to the medical facilities where BSD initially placed the systems and the reorders of the disposable microwave antennas as a positive indicator of its potential ongoing revenue stream.
For additional information on BSD Medical, please visit its website at www.BSDmedical.com
About MissionIR:
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html